nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Addisons’ other disease: primary biliary cirrhosis as a model autoimmune disease
|
Jones, David E J |
|
|
3 |
4 |
p. 351-356 |
artikel |
2 |
Allergy: the unmet need
|
Lee, Tak H |
|
|
3 |
4 |
p. 303-305 |
artikel |
3 |
Answers to the CME SAQs published in Clinical Medicine June/July 2003
|
|
|
|
3 |
4 |
p. 328 |
artikel |
4 |
Audit of proton pump inhibitor (PPI) prescribing: are NICE guidelines being followed?
|
Arasaradnam, RP |
|
|
3 |
4 |
p. 387-388 |
artikel |
5 |
Christopher Columbus, King Canute and SARS: the name does matter
|
|
|
|
3 |
4 |
p. 389-390 |
artikel |
6 |
Clinical approaches to the withdrawal of nutrition and hydration
|
Andrews, Keith |
|
|
3 |
4 |
p. 342-345 |
artikel |
7 |
Diagnosing HIV infection
|
Murrin, Richard |
|
|
3 |
4 |
p. 384 |
artikel |
8 |
Emergencies in oncology
|
Dark, Graham |
|
|
3 |
4 |
p. 306-310 |
artikel |
9 |
From the Editor
|
Watkins, Peter |
|
|
3 |
4 |
p. 301-302 |
artikel |
10 |
How to make medicine work – autocracy or democracy?
|
Roberts, Mark |
|
|
3 |
4 |
p. 374-375 |
artikel |
11 |
Impact of the two-week referral guideline on time to diagnosis and treatment in oesophago-gastric cancer
|
Logan, RFA |
|
|
3 |
4 |
p. 386-387 |
artikel |
12 |
Management of intestinal obstruction in malignant disease
|
Hirst, Becky |
|
|
3 |
4 |
p. 311-314 |
artikel |
13 |
Medical admission records can be improved by the use of a structured proforma
|
O’driscoll, Richard |
|
|
3 |
4 |
p. 385-386 |
artikel |
14 |
Medicine and art
|
Hoffenberg Sir, Raymond |
|
|
3 |
4 |
p. 382-383 |
artikel |
15 |
Olympic diabetes
|
Gallen, Ian W |
|
|
3 |
4 |
p. 333-337 |
artikel |
16 |
Oncology
|
|
|
|
3 |
4 |
p. 327-328 |
artikel |
17 |
Physicians in a foreign land
|
Greenwood, Richard |
|
|
3 |
4 |
p. 383-384 |
artikel |
18 |
Recent advances in mesothelioma
|
Dark, Graham |
|
|
3 |
4 |
p. 314-317 |
artikel |
19 |
Recent advances in oncological imaging
|
El-Haddad, K S |
|
|
3 |
4 |
p. 318-322 |
artikel |
20 |
Renal dysfunction: a novel indicator and potential promoter of cardiovascular risk
|
Ritz, Eberhard |
|
|
3 |
4 |
p. 357-360 |
artikel |
21 |
Samuel Johnson: his ills, his pills and his physician friends
|
Murray, T Jock |
|
|
3 |
4 |
p. 368-372 |
artikel |
22 |
Self-management in diabetes: training implications for professional carers
|
Day, John L |
|
|
3 |
4 |
p. 338-341 |
artikel |
23 |
Standards in medical record keeping
|
Mann, Robin |
|
|
3 |
4 |
p. 329-332 |
artikel |
24 |
The drug development process: from target discovery to the clinic
|
Newell, David R |
|
|
3 |
4 |
p. 323-326 |
artikel |
25 |
Using the placebo response in clinical practice
|
Hyland, Michael E |
|
|
3 |
4 |
p. 347-350 |
artikel |
26 |
Why does chronic inflammatory joint disease persist?
|
Buckley, Christopher D |
|
|
3 |
4 |
p. 361-366 |
artikel |